Companies / Santa Cruz Biotechnology / p-JNK (G-7) FITC
Santa Cruz Biotechnology

p-JNK (G-7) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG1; p-JNK Antibody (G-7) is an IgG1 κ mouse monoclonal p-JNK antibody that detects Thr 183 and Tyr 185 phosphorylated JNK1, JNK2 and JNK3 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA. p-JNK Antibody (G-7) is available as the non-conjugated anti-p-JNK antibody form, as well as multiple conjugated forms of anti-p-JNK antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The mitogen-activated protein (MAP) kinases ERK 1 and ERK 2 are proline-directed kinases that are activated through concomitant phosphorylation of tyrosine and threonine residues. The JNK family, which includes JNK1, JNK2, and JNK3, is distantly related to the MAP kinase family, members of which are activated by dual phosphorylation at a Thr-Pro-Tyr motif, specifically at Thr 183 and Tyr 185 residues, in response to ultraviolet (UV) light. This motif is divergent from the Thr-Glu-Tyr motif characteristic of the MAP kinase family. JNK is phosphorylated by JNK-activating kinase (JNKK1 and JNKK2), which are members of the MEK family. Activated JNK mediates the phosphorylation of c-Jun at the amino terminal serine regulatory sites, Ser 63 and Ser 73, which stimulates the transactivation function of c-Jun.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.